Stay updated on Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Sign up to get notified when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.

Latest updates to the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.5.3, updating the version tag from v3.5.2. This indicates the current revision of the page has been refreshed.SummaryDifference0.1%

- Check20 days agoChange DetectedNew links/resources related to **Idiopathic Pulmonary Fibrosis**, including a **Genetic and Rare Diseases Information Center** reference, were added to the study page.SummaryDifference0.2%

- Check27 days agoChange DetectedAdded site revision label v3.5.2 and removed v3.5.0. This update does not modify trial content or user-facing information.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the 'Interstitial lung disease 2' term and the 'Genetic and Rare Diseases Information Center' entry under Resources.SummaryDifference0.2%

- Check56 days agoChange DetectedThe site revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated the site revision to v3.4.3; the previous revision v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to Jaktinib Hydrochloride Tablets in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Jaktinib Hydrochloride Tablets in IPF Clinical Trial page.